Oxaliplatin enhances TRAIL‐induced apoptosis in gastric cancer cells by CBL‐regulated death receptor redistribution in lipid rafts
- 15 February 2009
- journal article
- Published by Wiley in FEBS Letters
- Vol. 583 (5), 943-948
- https://doi.org/10.1016/j.febslet.2009.02.014
Abstract
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a member of the tumor necrosis factor family that selectively induces apoptosis in cancer cells. However, gastric cancer cells are insensitive to TRAIL. In the present study, we show that oxaliplatin enhanced TRAIL-induced apoptosis of MGC803, BGC823, and SGC7901 cells. Oxaliplatin promoted death receptor 4 (DR4) and death receptor 5 (DR5) clustering into aggregated lipid rafts, while the cholesterol-sequestering agent nystatin partially prevented lipid raft aggregation, DR4 and DR5 clustering, and reduced apoptosis. Furthermore, the expression of the casitas B-lineage lymphoma (Cbl) family was downregulated by oxaliplatin. Transfection of c-Cbl or Cbl-b partially reversed oxaliplatin-induced lipid raft aggregation. These results indicated that oxaliplatin enhanced TRAIL-induced gastric cancer cell apoptosis at least partially through Cbl-regulated death receptor redistribution in lipid rafts.Keywords
This publication has 21 references indexed in Scilit:
- Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cellsGynecologic Oncology, 2008
- Low concentrations of doxorubicin sensitizes human solid cancer cells to tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL)‐receptor (R) 2‐mediated apoptosis by inducing TRAIL‐R2 expressionCancer Science, 2007
- Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate DataJournal of Clinical Oncology, 2006
- Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECFBritish Journal of Cancer, 2005
- Expression of tumour necrosis factor-related apoptosis-inducing ligand death receptors in sporadic and hereditary colorectal tumours: Potential targets for apoptosis inductionEuropean Journal Of Cancer, 2005
- Upregulation of FLIPSby Akt, a possible inhibition mechanism of TRAIL‐induced apoptosis in human gastric cancersCancer Science, 2003
- The death-inducing signalling complex is recruited to lipid rafts in Fas-induced apoptosisBiochemical and Biophysical Research Communications, 2002
- An essential role for membrane rafts in the initiation of Fas/CD95‐triggered cell death in mouse thymocytesEMBO Reports, 2002
- The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tractOncogene, 1999
- Two CD95 (APO-1/Fas) signaling pathwaysThe EMBO Journal, 1998